IGC Pharma Inc (IGC)
0.4595
+0.03
(+6.86%)
USD |
NYAM |
Apr 26, 12:41
IGC Pharma Price: 0.4595 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 0.4375 | 0.4479 | 0.417 | 0.43 | 230262.0 |
Apr 24, 2024 | 0.4626 | 0.4688 | 0.413 | 0.439 | 428730.0 |
Apr 23, 2024 | 0.47 | 0.49 | 0.4162 | 0.4566 | 519570.0 |
Apr 22, 2024 | 0.4927 | 0.508 | 0.42 | 0.4451 | 648768.0 |
Apr 19, 2024 | 0.4857 | 0.508 | 0.47 | 0.49 | 620504.0 |
Apr 18, 2024 | 0.5661 | 0.57 | 0.47 | 0.4761 | 1.362M |
Apr 17, 2024 | 0.5386 | 0.65 | 0.526 | 0.5865 | 3.171M |
Apr 16, 2024 | 0.4257 | 0.66 | 0.4204 | 0.486 | 5.128M |
Apr 15, 2024 | 0.434 | 0.4392 | 0.40 | 0.4392 | 480646.0 |
Apr 12, 2024 | 0.5357 | 0.5357 | 0.4201 | 0.4401 | 1.127M |
Apr 11, 2024 | 0.553 | 0.553 | 0.51 | 0.53 | 405164.0 |
Apr 10, 2024 | 0.5648 | 0.5747 | 0.5093 | 0.531 | 906116.0 |
Apr 09, 2024 | 0.5701 | 0.60 | 0.54 | 0.575 | 842212.0 |
Apr 08, 2024 | 0.64 | 0.6669 | 0.54 | 0.62 | 1.354M |
Apr 05, 2024 | 0.71 | 0.80 | 0.60 | 0.6495 | 2.730M |
Apr 04, 2024 | 0.74 | 0.9099 | 0.6701 | 0.6899 | 6.669M |
Apr 03, 2024 | 0.5354 | 0.65 | 0.53 | 0.6404 | 2.742M |
Apr 02, 2024 | 0.4971 | 0.65 | 0.48 | 0.5355 | 2.887M |
Apr 01, 2024 | 0.42 | 0.495 | 0.403 | 0.476 | 1.225M |
Mar 28, 2024 | 0.407 | 0.4149 | 0.3912 | 0.40 | 314666.0 |
Mar 27, 2024 | 0.408 | 0.409 | 0.3751 | 0.4065 | 353130.0 |
Mar 26, 2024 | 0.40 | 0.4354 | 0.353 | 0.399 | 1.025M |
Mar 25, 2024 | 0.3927 | 0.4169 | 0.376 | 0.40 | 546620.0 |
Mar 22, 2024 | 0.348 | 0.38 | 0.34 | 0.376 | 1.158M |
Mar 21, 2024 | 0.3426 | 0.357 | 0.3263 | 0.34 | 423114.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.2652
Minimum
Jan 23 2024
3.10
Maximum
Feb 10 2021
0.8603
Average
0.6402
Median
Price Benchmarks
CEL-SCI Corp | 1.43 |
AIM ImmunoTech Inc | 0.424 |
NovaBay Pharmaceuticals Inc | 0.085 |
Protalix BioTherapeutics Inc | 1.14 |
Palatin Technologies Inc | 1.715 |
Price Related Metrics
PS Ratio | 21.18 |
Price to Book Value | 3.235 |
Earnings Yield | -56.58% |
Market Cap | 29.29M |